Insilico Medicine

Insilico Medicine nets $110M for new trials, robotic helpers

Insilico's series E round was led by Hong Kong-based firm Value Partners, and joined by Insilico’s previous investors plus unnamed first-time backers.

Conor Hale Mar 12, 2025 11:00am

Insilico posts benchmarks from 22 AI-designed drug candidates

Feb 11, 2025 9:00am

Insilico Medicine, Menarini sign second $500M+ cancer drug deal

Jan 10, 2025 9:30am

After phase 2 data, Insilico plots pivotal lung disease trial

Nov 12, 2024 1:34pm

abstract concept of AI and precision medicine and RD

Big pharma, biotech ‘won't necessarily be symbiotic’ in AI: S&P

Oct 2, 2024 11:23am

Insilico launches AI assistant for drafting research papers

Jul 23, 2024 3:00pm